Latest News about MRVI
Recent news which mentions MRVI
The Daily Biotech Pulse: Kodiak Sinks On Adverse Study Outcome, Marinus Flags Delay In Clinical Trial, Mainz Biomed Gains On Positive Regulatory Development
February 23, 2022
From Benzinga
Earnings Scheduled For February 23, 2022
February 23, 2022
From Benzinga
The Week Ahead In Biotech (Feb. 20-26): Reata Awaits FDA Decision, Bausch Health, Moderna Lead Earnings News Flow
February 20, 2022
From Benzinga
3 Biotech Stocks That Could Deliver 5X Gains by 2030
January 30, 2022
From Motley Fool
56 Biggest Movers From Friday
November 29, 2021
From Benzinga
48 Stocks Moving In Friday's Mid-Day Session
November 26, 2021
From Benzinga
Tickers
MRVI
From Motley Fool
The Daily Biotech Pulse: Valneva Inks COVID-19 Vaccine Supply Contract In Europe, I-Mab Spikes On China Deal, DermTech Sinks On Guidance
November 10, 2021
From Benzinga
The Week Ahead In Biotech (Nov. 7-Nov. 13): Earnings Taper Off, Multiple Conference Presentations, IPOs And More
November 08, 2021
From Benzinga
92 Biggest Movers From Friday
November 08, 2021
From Benzinga
54 Biggest Movers From Friday
October 04, 2021
From Benzinga
60 Biggest Movers From Friday
September 13, 2021
From Benzinga
41 Stocks Moving In Friday's Mid-Day Session
September 10, 2021
From Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
September 10, 2021
From Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
September 10, 2021
From InvestorPlace
20 Stocks Moving in Friday's Pre-Market Session
September 10, 2021
From Benzinga
The Daily Biotech Pulse: MacroGenics' Clinical Trial Disappointment, Sanofi to Buy Kadmon, Alector Loses 2 Key Executives, ADMA's FDA Nod
September 08, 2021
From Benzinga
From Benzinga
Stocks That Hit 52-Week Highs On Monday
August 23, 2021
From Benzinga
From Benzinga
From Benzinga
Mid-Afternoon Market Update: Dow Tumbles Over 400 Points; Virpax Pharmaceuticals Shares Spike Higher
August 17, 2021
From Benzinga
From Benzinga
The Daily Biotech Pulse: FDA Rejects FibroGen's Anemia Drug, Crinetics Gains On Positive Readout, BioCryst Withdraws Public Offering
August 11, 2021
From Benzinga
Tickers
MRVI
From Motley Fool
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.